Sustainability Commitment

Our commitment reflects our focus on improving health and safety through a people-centric culture, ethical leadership, and climate stewardship.

Purpose-Driven and Future-Focused

Our mission to improve patient health and safety guides everything we do—and shapes our commitment to sustainability. This deep sense of responsibility is reflected in how we operate as a business, with a focus on People-Centric Culture, Ethical Leadership, and Climate Stewardship.

Our SBTi-validated emissions reduction targets and EcoVadis Commitment badge reflect continued progress, and as part of our journey, have detailed action plans to continuously improve our rating.

esg-badges
ProPharma 2025 Corporate Sustainability Report

2025 Sustainability Report

 
Creating meaningful change takes continued focus, collaboration, and accountability. Our 2025 Sustainability Report offers a closer look at the work underway across our global organization, the progress we have made, and the opportunities ahead. It reflects how we are turning our commitments into action and building a more sustainable future, one step at a time.
 

Sustainability Starts with Our Core Principles

 

People-Centric Culture

We foster a culture of respect, inclusion, and opportunity to enable employee well-being, professional growth, and a culture of belonging.

  • Dedicated DEI program and leadership
  • Risk inventory assessments
  • Volunteer and flexible time off
  • Wellness benefits, annual programming, and challenges
  • Employee Resource Groups and clubs
  • Feedback and upward mobility
  • Charity match programs
  • Talent acquisition and retention 
  • Mentorship programs
  • Training and continuous education opportunities
  • And more!
smiling-woman-high-fiving-coworker-as-983431523-650x425
Confident worker woman looking at camera

Ethical Leadership

We uphold integrity, transparency, and accountability in all aspects of our business, ensuring responsible decision-making, data privacy, and compliance with global standards.

  • Advanced Data Security and Privacy Programs
  • Compliance with labor laws within each operating region
  • Quarterly Board Reporting on Sustainability Program
  • Transparent and accessible leadership through Town Halls

Climate Stewardship

We are focused on minimizing our environmental footprint through science-based climate action, responsible resource management, and continuous improvement in sustainability practices.

  • Remote workforce commitment
  • Employee Education & Green Team
  • EcoVadis Commitment Badge
  • Approved near- and long-term science-based emissions reduction targets with the Science Based Targets initiative (SBTi)
  • Annual energy and carbon reporting

Our near-term and long-term emissions reduction targets have been independently validated by SBTi Services in accordance with the SBTi Near-Term and Net-Zero Criteria.

Group of professional women talking in a lobby
Gradient Image

Driving Progress Through Collaboration 

Our Sustainability Program is guided by a dedicated Steering Committee made up of executive and senior leaders from across our global operations. This cross-functional group is responsible for driving progress across all pillars of our sustainability strategy. The committee ensures accountability, approves new initiatives, and proactively plans for evolving regional requirements and standards to maintain meaningful, forward-looking impact.

News & Insights

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture

September 28, 2026

Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture

Explore how inspection readiness is evolving in the pharmaceutical industry, emphasizing continuous compliance, quality culture, and global regulatory expectations.

Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and Market Opportunities

August 24, 2026

Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and ...

Explore the complex regulatory landscape of Eastern Europe for marketing authorization, and discover strategic opportunities for market entry and growth.

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

July 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

October 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

From Feasibility to First Patient In: How to Streamline Study Start-Up  

September 30, 2026

From Feasibility to First Patient In: How to Streamline Study Start-Up  

Clinical trial delays often begin long before study conduct, with critical decisions made during feasibility and study start-up shaping the success of the entire trial. Join this webinar to discover...

News & Insights

What It Takes to Build a Successful Global Medical Information Program in Veterinary Medicine

October 13, 2026

What It Takes to Build a Successful Global Medical Information Program in Veteri...

Learn how to build a successful global medical information program in veterinary medicine, navigating complexity and enhancing customer support across diverse markets.

Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture

September 28, 2026

Inspection Readiness: From Regulatory Compliance to Sustainable Quality Culture

Explore how inspection readiness is evolving in the pharmaceutical industry, emphasizing continuous compliance, quality culture, and global regulatory expectations.

Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and Market Opportunities

August 24, 2026

Marketing Authorization in Eastern Europe: Navigating Regulatory Complexity and ...

Explore the complex regulatory landscape of Eastern Europe for marketing authorization, and discover strategic opportunities for market entry and growth.

Previous Post Arrow Next Post Arrow
ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability for ANDA Submission Development

July 8, 2026

ProPharma Advances Technology Enablement Strategy with AI-Assisted Capability fo...

ProPharma unveils an AI-assisted capability to enhance ANDA submission development, improving efficiency and maintaining regulatory excellence for clients.

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and HTA Capabilities

June 18, 2026

ProPharma Welcomes Kevin van Dooren to Strengthen Integrated EU Regulatory and H...

ProPharma welcomes Kevin van Dooren as Vice President, HEOR and Market Access, strengthening integrated EU regulatory, HTA, reimbursement, and market access capabilities for life sciences companies.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Infographic Flexible Resourcing Without Limits: Scaling Capabilities Across the Development Lifecycle - ProPharma

September 18, 2026

Flexible Resourcing Without Limits: Scaling Capabilities Across the Development ...

Development complexity doesn’t increase in a straight line. As programs progress from discovery through Phase III, submission, and post-approval, demands for medical writing, biometrics, clinical...

Case Study Achieving Continuous Audit Readiness Across a Global Medical Information Program - ProPharma

August 3, 2026

Achieving Continuous Audit Readiness Across a Global Medical Information Program

Maintaining continuous audit readiness across a global Medical Information operation requires more than periodic audit preparation. Organizations operating across multiple countries and affiliates...

Case Study Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation - ProPharma

July 23, 2026

Inspection-Ready AI: Building Quality Frameworks That Keep Pace with Innovation

As artificial intelligence becomes increasingly embedded across life sciences, organizations face a growing challenge: ensuring quality and compliance frameworks evolve alongside rapidly advancing...

Previous Resource Arrow Next Resource Arrow
Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

November 12, 2026

Empowering Sites, Engaging Patients: Strategies to Improve Clinical Trial Performance 

Sites are being asked to do more than ever before while balancing increasing trial complexity, patient expectations, and operational demands. Join this webinar to explore how flexible, integrated...

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

October 22, 2026

Reg Reels: Your Snapshot of the Latest Pharmacovigilance Regulatory Developments

Tired of working through lengthy regulatory documents? Join Reg Reels for a concise, video-led look at the latest pharmacovigilance developments from the EMA, FDA, and MHRA. Our experts will...

From Feasibility to First Patient In: How to Streamline Study Start-Up  

September 30, 2026

From Feasibility to First Patient In: How to Streamline Study Start-Up  

Clinical trial delays often begin long before study conduct, with critical decisions made during feasibility and study start-up shaping the success of the entire trial. Join this webinar to discover...

Previous Webinar Arrow Next Webinar Arrow